These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13758726)

  • 1. Evaluation of bisacodyl (Dulcolax) as a laxative for routine postpartum use.
    LANE RE
    Obstet Gynecol; 1961 Apr; 17():453-4. PubMed ID: 13758726
    [No Abstract]   [Full Text] [Related]  

  • 2. The laxative action of bisacodyl.
    LAMPHIER TA; ALFANO BF; GOLDSTEIN RH
    Am J Proctol; 1961 Feb; 12():38-42. PubMed ID: 13758573
    [No Abstract]   [Full Text] [Related]  

  • 3. EVALUATION OF A NEW CONTACT LAXATIVE, BISACODYL (DULCOLAX), IN OBSTETRICS AND GYNECOLOGY.
    SMITH JJ; SCHWARTZ ED
    West J Surg Obstet Gynecol; 1964; 72():177-80. PubMed ID: 14144385
    [No Abstract]   [Full Text] [Related]  

  • 4. EVALUATION OF A NEW ORAL LAXATIVE FOR ROUTINE POSTPARTUM USE.
    BERNARD LI; JAROLIM C; TUMANENG L
    IMJ Ill Med J; 1965 Jun; 127():678-9. PubMed ID: 14295635
    [No Abstract]   [Full Text] [Related]  

  • 5. The therapeutic usefulness of dulcolax (biśacodyl), a new nonpurgative laxative.
    DREILING DA; FISCHL A; FERNANDEZ O
    Am J Dig Dis; 1959 Apr; 4(4):311-20. PubMed ID: 13637059
    [No Abstract]   [Full Text] [Related]  

  • 6. The concomitant use of an osmotic laxative, magnesium sulphate, and a stimulant laxative, bisacodyl, does not enhance the laxative effect.
    Ikarashi N; Mimura A; Kon R; Iizasa T; Omodaka M; Nagoya C; Ishii M; Toda T; Ochiai W; Sugiyama K
    Eur J Pharm Sci; 2012 Jan; 45(1-2):73-8. PubMed ID: 22085681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness of bisacodyl as a laxative in mentally defective patients.
    CARTER CH
    J Fla Med Assoc (1914); 1962 Aug; 49():135-7. PubMed ID: 13876948
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of constipation in the postpartum patient.
    MUCHOW GC; NOLL LE
    J Lancet; 1961 Jun; 81():249. PubMed ID: 13773422
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of Chronic Functional Constipation during Pregnancy and Lactation].
    Gharehbaghi K; Gharehbaghi DR; Wierrani F; Sliutz G
    Z Geburtshilfe Neonatol; 2016 Feb; 220(1):9-15. PubMed ID: 26866689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the possibilities of use of a new laxative (Dulcolax) in combination with gynecological examinations and operations].
    KROKFORS E
    Med Welt; 1962 Jul; 29():1558-60. PubMed ID: 14459793
    [No Abstract]   [Full Text] [Related]  

  • 11. USE OF A CONTACT LAXATIVE SOLUTION (DULCOLAX) AS AN ADJUNCT IN COLOSTOMY CONTROL.
    STEVENSON TB; HAWK JC
    Am Surg; 1964 Feb; 30():118-22. PubMed ID: 14118530
    [No Abstract]   [Full Text] [Related]  

  • 12. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.
    Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ
    Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Use of Bisacodyl in Pediatric Functional Constipation Refractory to Conventional Therapy.
    Bonilla S; Nurko S; Rodriguez L
    J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):288-291. PubMed ID: 32459741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bisacodyl as laxative in Belgian pharmacy].
    De Braekeleer K; Vandersteen L
    J Pharm Belg; 2016 Jun; (2):4-9. PubMed ID: 30281225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the Safety Profiles of Laxatives in Pregnant Women.
    Brigstocke S; Yu V; Nee J
    J Clin Gastroenterol; 2022 Mar; 56(3):197-203. PubMed ID: 35050942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a rectal suppository of bisacodyl (dulcolax) in geriatric patients.
    PINCOCK JG
    Can Med Assoc J; 1960 Jan; 82(5):268-9. PubMed ID: 14433035
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments.
    Müller-Lissner S
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):391-401. PubMed ID: 23425050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BISACODYL (DULCOLAX) ITS VALUE IN A 'BOWEL HABIT' PROGRAM.
    GHOLZ LM
    Ariz Med; 1965 Mar; 22():197-200. PubMed ID: 14261097
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetics and laxative effect of bisacodyl following administration of various dosage forms].
    Roth W; Beschke K
    Arzneimittelforschung; 1988 Apr; 38(4):570-4. PubMed ID: 3401271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bis-(p-hydroxyphenyl)-pyridyl-2-methane: The common laxative principle of Bisacodyl and sodium picosulfate.
    Jauch R; Hankwitz R; Beschke K; Pelzer H
    Arzneimittelforschung; 1975 Nov; 25(11):1796-1800. PubMed ID: 1243088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.